Literature DB >> 31991140

Morroniside enhances angiogenesis and improves cardiac function following acute myocardial infarction in rats.

Tingting Liu1, Fangling Sun1, Jiamin Cui2, Songyang Zheng1, Zijie Li2, Deyu Guo1, Xin Tian1, Zixin Zhu1, Wenrong Zheng1, Yufeng Wang1, Wen Wang3.   

Abstract

Angiogenesis is critical for re-establishing blood supply to the ischemic myocardium after acute myocardial infarction (AMI). This study aimed to investigate the effects of morroniside on angiogenesis after AMI and explored associated proangiogenic mechanisms. A rat model of AMI was established by ligation of the left anterior descending coronary artery followed by administration of three doses of morroniside. Immunofluorescence staining was performed to identify newly generated endothelial cells and arterioles. The protein expression levels associated with angiogenesis were examined by western blots. Echocardiography was used to examine cardiac function. Our data revealed that morroniside promoted angiogenesis and improved cardiac function in rats with AMI. The proangiogenic effect of morroniside might be mediated by the VEGFA/VEGF receptor 2 signaling pathway.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute myocardial infarction; Angiogenesis; Cardiac function; Morroniside; VEGF/VEGF receptor 2 signaling pathway

Year:  2020        PMID: 31991140     DOI: 10.1016/j.ejphar.2020.172954

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

Review 1.  Secondary Metabolites with Biomedical Applications from Plants of the Sarraceniaceae Family.

Authors:  Ileana Miclea
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

2.  Morroniside Protects Human Granulosa Cells against H2O2-Induced Oxidative Damage by Regulating the Nrf2 and MAPK Signaling Pathways.

Authors:  Yucong Ma; Guimin Hao; Xiaohua Lin; Zhiming Zhao; Aimin Yang; Yucong Cao; Shuancheng Zhang; Lijie Fan; Jingran Geng; Yu Zhang; Jingwei Chen; Cuimiao Song; Ming He; Huilan Du
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-09       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.